浏览全部资源
扫码关注微信
广州中医药大学 基础医学院,广州 510006
Published:20 November 2023,
Published Online:16 March 2023,
Received:29 November 2022,
扫 描 看 全 文
高宇容,张亚星,巫芳华等.补阳还五汤通过激活脂联素通路减轻大鼠脑缺血再灌注后炎症损伤[J].中国实验方剂学杂志,2023,29(22):11-20.
GAO Yurong,ZHANG Yaxing,WU Fanghua,et al.Buyang Huanwutang Alleviates Inflammatory Injury After Cerebral Ischemia-reperfusion in Rats via Activating Adiponectin Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(22):11-20.
高宇容,张亚星,巫芳华等.补阳还五汤通过激活脂联素通路减轻大鼠脑缺血再灌注后炎症损伤[J].中国实验方剂学杂志,2023,29(22):11-20. DOI: 10.13422/j.cnki.syfjx.20230706.
GAO Yurong,ZHANG Yaxing,WU Fanghua,et al.Buyang Huanwutang Alleviates Inflammatory Injury After Cerebral Ischemia-reperfusion in Rats via Activating Adiponectin Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(22):11-20. DOI: 10.13422/j.cnki.syfjx.20230706.
目的
2
研究补阳还五汤通过激活脂联素(APN)通路减轻大鼠脑缺血再灌注后炎症损伤、改善神经功能。
方法
2
将雄性SD大鼠随机分为假手术组、模型组、补阳还五汤组和补阳还五汤联合APN抑制剂(GW9662)组。假手术组仅分离组织剥离血管,模型组建立大鼠大脑中动脉闭塞(MCAO)模型,补阳还五汤组给予补阳还五汤灌胃16 g·kg
-1
,2次/d。补阳还五汤+GW9662组于造模术前30 min给予GW9662腹腔注射4 mg·kg
-1
,术后给予补阳还五汤灌胃16 g·kg
-1
,2次/d。脑缺血再灌注24 h后,采用免疫荧光(IF)法观察大鼠脑组织中脂联素受体1(AdipoR1)的表达,以及AdipoR1与神经元标记物(NeuN)、小胶质细胞标记物(Iba1)的共定位;采用酶联免疫吸附测定法(ELISA)检测大鼠血清和脑组织APN含量;行为学检测中,横木行走测试观察大鼠平衡能力,抓力测试观察大鼠肢体力量恢复情况。免疫荧光法检验髓过氧化物酶(MPO)的表达;蛋白免疫印迹法(Western blot)检测脑组织肿瘤坏死因子-
α
(TNF-
α
)、白细胞介素-1
β
(IL-1
β
)、白细胞介素-6(IL-6)和白细胞介素-10(IL-10)表达水平。
结果
2
与假手术组比较,模型组AdipoR1表达升高(
P
<
0.01),血清和脑组织APN含量降低(
P
<
0.05,
P
<
0.01),横木行走测试评分增高(
P
<
0.01),前肢抓力减弱(
P
<
0.01),MPO、TNF-
α
、IL-1
β
和IL-6表达升高(
P
<
0.01),IL-10表达降低(
P
<
0.01)。与模型组比较,补阳还五汤组AdipoR1表达升高(
P
<
0.01),血清和脑组织APN含量升高(
P
<
0.05,
P
<
0.01),横木行走评分降低无统计学意义,前肢抓力显著提升(
P
<
0.01),MPO、TNF-
α
、IL-1
β、
IL-6表达降低(
P
<
0.01),IL-10表达升高(
P
<
0.01)。补阳还五汤联合GW9662使用后部分作用被抑制。
结论
2
补阳还五汤可减轻脑缺血再灌注大鼠炎症损伤,改善神经功能,其作用机制可能与APN通路的激活有关。
Objective
2
To investigate the effects of Buyang Huanwutang (BYWHT) on reducing inflammatory injury and improving neurological function after cerebral ischemia-reperfusion in rats via activating the adiponectin (APN) pathway.
Method
2
Male SD rats were randomized into sham, model, BYHWT (16 g·kg
-1
, twice a day), and BYHWT + APN inhibitor (GW9662) groups. In the sham group, blood vessels were isolated. The rat model of middle cerebral artery occlusion (MCAO) was established. The rats in the BYHWT+GW9662 group was treated with subcutaneous injection of GW9662 at 4 m·kg
-1
30 min before MCAO surgery and BYHWT at 16 g·kg
-1
by gavage after MCAO surgery, once in the morning and once in the evening. The immunofluorescence (IF) assay was employed to observe the expression of adiponectin receptor 1 (AdipoR1) and the colocalization of AdipoR1 with neuronal nuclei (NeuN) and ionized calcium binding adaptor molecule 1 (Iba1) in the brain. Enzyme-linked immunosorbent assay (ELISA) was employed to detect the expression of APN in the serum and brain. The balance beam test was carried out to examine the balance ability, and the grasping test to assess the recovery of limb strength. The immunofluorescence assay was used to detect the expression of myeloperoxidase (MPO). Western blot was employed to determine the expression of tumor necrosis factor-alpha (TNF-
α
), interleukin (IL)-1
β
, IL-6, and IL-10 and in the brain.
Result
2
Compared with the sham group, the modeling promoted the expression of AdipoR1 (
P
<
0.01), lowered the APN levels in the serum and brain (
P
<
0.05,
P
<
0.01), increased the score in the balance beam test (
P
<
0.01), and decreased the grasping strength of forepaw (
P
<
0.01), which were accompanied with increased MPO, TNF-
α
, IL-1
β
,
and IL-6 levels (
P
<
0.01) and decreased IL-10 level (
P
<
0.01). Compared with the model group, BYHWT promoted the expression of AdipoR1 (
P
<
0.01), elevated APN levels in the serum and brain (
P
<
0.05,
P
<
0.01), and increased the grasping strength of forepaw (
P
<
0.01), which were accompanied with lowered MPO, TNF-
α
, IL-1
β
,
and IL-6 levels (
P
<
0.01) and elevated IL-10 level (
P
<
0.01). All the above effects were partially blocked by GW9662.
Conclusion
2
BYHWT can reduce inflammatory injury and improve neurological function in the rat model of cerebral ischemia-reperfusion by activating the APN pathway.
补阳还五汤脑缺血再灌注脂联素脂联素受体1炎症
Buyang Huanwutangcerebral ischemia-reperfusionadiponectinadiponectin receptor 1inflammation
TSAO C W,ADAY A W,MARTIN S S,et al.Heart disease and stroke statistics-2022 update:A report from the american heart association[J].Circulation,2022,145(8):e153-e639.
POWERS W J,RABINSTEIN A A,TIRSCHWELL D L,et al.American heart association stroke council.2018 guidelines for the early management of patients with acute ischemic stroke:A guideline for healthcare professionals from the American heart association/American stroke association[J].Stroke,2018,49(3):e46-e110.
FU Y,LIU Q,ANRATHER J,et al.Immune interventions in stroke[J].Nat Rev Neurol,2015,11(9):524-535.
KRAKOFF J,FUNAHASHI T,LINDSAY R S,et al.Inflammatory markers,adiponectin,and risk of type 2 diabetes in the Pima Indian[J].Diabetes Care,2003,26(6):1745-1751.
THUNDYIL J,PAVLOVSKI D,ARUMUGAM T V,et al.Adiponectin receptor signalling in the brain[J].Br J Pharmacol,2012,165(2):313-327.
清·王清任.医林改错[M].欧阳兵,张成博,点校.天津:天津科学技术出版社,1999,36.
李均展.补阳还五汤对老年缺血性脑卒中患者神经功能及炎症因子水平的影响[J].光明中医,2021,36(11):1827-1829.
温志浩,卢健棋,沈瑜,等.补阳还五汤对急性ST段抬高型心肌梗死患者介入术后血浆脂联素影响的研究[J].辽宁中医杂志,2018,45(4):747-749.
LONGA E,WEINSTEIN P,CARLSON S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
魏伟,吴希美,李元建.药理实验方法学[M].第4版.北京:人民卫生出版社,2010:1439-1442.
巫芳华,刘玉莲,刘微,等.补阳还五汤通过甲酰肽受体2减轻大鼠脑缺血再灌注后氧化应激损伤[J].中国实验方剂学杂志,2021,27(18):9-15.
SUN L,XU Y W,CHENG Y,et al.12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ:A possible neuroprotective effect in ischemic brain[J].J Lipid Res,2015,56(3):502-514.
RAWLINSON C,JENKINS S,CHEN R,et al.Post-ischaemic immunological response in the brain:Targeting microglia in ischaemic stroke therapy[J].BrainSci,2020,10(3):E159.
任靓明,田红旗.炎症因子及其抑制剂对脑缺血再灌注损伤作用的研究进展[J].中国医药导报,2021,18(12):61-64.
单玉栋,高维娟.补阳还五汤防治脑缺血再灌注损伤的研究进展[J].中医药学报,2021,49(8):115-120.
王紫艳,李磊,尤越,等.补阳还五汤对多因素诱导急性血瘀证模型大鼠血小板功能及相关炎性因子的影响[J].中国实验方剂学杂志,2022,28(21):1-9.
甘海燕,李琳,储利胜,等.补阳还五汤调控小胶质细胞/巨噬细胞极化抑制大鼠脑缺血后炎症反应研究[J].浙江中医药大学学报,2019,43(1):1-6.
ZHAO L,CHEN S,ZHANG J H,et al.Recombinant CTRP9 administration attenuates neuroinflammation via activating adiponectin receptor 1 after intracerebral hemorrhage in mice[J].J Neuroinflammation,2018,15(1):215.
NICOLAS S,CAZARETH J,PETIT-PAITEL A,et al.Globular adiponectin limits microglia pro-inflammatory phenotype through an AdipoR1/NF-κB signaling pathway[J].Front Cell Neurosci,2017,11:352.
RASTEGAR S,PARIMISETTY A,DIOTEL N,et al.Expression of adiponectin receptors in the brain of adult zebrafish and mouse:Links with neurogenic niches and brain repair[J].J Comp Neurol,2019,527(14):2317-2333.
THUNDYIL J,PAVLOVSKI D,ARUMUGAM T V,et al.Adiponectin receptor signalling in the brain[J].Br J Pharmacol,2012,165(2):313-327.
PARKER-DUFFEN J L,NAKAMURA K,SILVER M,et al.T-cadherin is essential for adiponectin-mediated revascularization[J].J Biol Chem,2013,288(34):24886-24897.
KIM M W,ABID N B,KIM M O,et al.Suppression of adiponectin receptor 1 promotes memory dysfunction and Alzheimer's disease-like pathologies[J].Sci Rep,2017,7(1):12435.
THUNDYIL J,TANG S C,ARUMUGAM T V,et al.Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death[J].Exp Transl Stroke Med,2010,2(1):15.
XU N,ZHANG Y,ZHANG J H,et al.Adiponectin attenuates neuronal apoptosis induced by hypoxia-ischemia via the activation of AdipoR1/APPL1/LKB1/AMPK pathway in neonatal rats[J].Neuropharmacology,2018,133:415-428.
GUO M,LI C,LU X Y,et al.Role of the adipose PPARγ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors[J].Mol Psychiatry,2017,22(7):1056-1068.
LIN C H,LIAO L Y,HSUEH C M,et al.Microglia-derived adiposomes are potential targets for the treatment of ischemic stroke[J].Cell Mol Neurobiol,2019,39(5):591-604.
SHEN X,LI H,DING X,et al.Telmisartan ameliorates AdipoR1 and adipoR2 expression via PPAR-γ activation in the coronary artery and VSMCs[J].Biomed Pharmacother,2017,95:129-136.
SHEN X,LI H,DING X,et al.Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs[J].Mol Cell Endocrinol,2012,363(1/2):27-35.
仝小林,段娟.肥胖新论[J].同济大学学报:医学版,2010,31(3):6-8.
CIANCARELLI I,MORONE G,IOSA M,et al.Adipokines as potential biomarkers in the neurorehabilitation of obese stroke patients[J].Curr Neurovasc Res,2020,17(4):437-445.
MIAO J,SHEN L H,YANG G Y,et al.Overexpression of adiponectin improves neurobehavioral outcomes after focal cerebral ischemia in aged mice[J].CNS Neurosci Ther,2013,19(12):969-977.
CHEN B,LIAO W Q,CAMPBELL W,et al.Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action[J].Brain Res,2009,1273:129-137.
YIGITKANLI K,ZHENG Y,VAN LEYEN K,et al.Increased 12/15-lipoxygenase leads to widespread brain injury following global cerebral ischemia[J].Transl Stroke Res,2017,8(2):194-202.
LIU Y,WANG H,ZHU Y,et al.The protective effect of nordihydroguaiaretic acid on cerebral ischemia/reperfusion injury is mediated by the jnk pathway[J].Brain Res,2012,22:73-81.
CHEN S,CHEN H,SHEN J,et al.Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury:Potential application of natural compounds[J].Front Physiol,2020,11:433.
罗武生,郭兆贵.用髓过氧化酶法定量测定心肌组织中的中性白细胞[J].中国药理学通报,1990,4:264-266.
WAJE-ANDREASSEN U,KRAKENES J,ULVESTAD E,et al.IL-6:Anearly marker for outcome in acute ischemic stroke[J].Acta Neurol Scand,2005,111:360-365.
KRAKOFF J,FUNAHASHI T,STEHOUWER C D,et al.Inflammatory markers,adiponectin,and risk of type 2 diabetes in the Pima Indian[J].Diabetes Care,2003,26:1745-1751.
BRUUN J M,LIHN A S,VERDICH C,et al.Regulation of adiponectin by adipose tissue-derived cytokines:In vivo and in vitro investigations in humans[J].Am J Physiol Endocrinol Metab,2003,285:E527-E533.
董志强,向庆伟,陈延,等.补阳还五汤对TLR4介导脑缺血大鼠海马炎症损伤的作用[J].现代中西医结合杂志,2019,28(34):3777-3781,3876.
0
Views
31
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution